Merck to pay at least $21.8 million to settle Vioxx lawsuits in Canada.
The Toronto Star reports on the Vioxx class action lawsuit and Pharmaceutical giant Merck has agreed to pay between $21.8 and $36.8 million to settle the case.For full story, please click here.
View the post titled Merck to pay at least $21.8 million to settle Vioxx lawsuits in Canada.Canadians who took controversial Vioxx drug may be eligible for compensation.
Global News reports on the Vioxx settlement.For full details, please click here.
View the post titled Canadians who took controversial Vioxx drug may be eligible for compensation.Vioxx Settlement Reached
A settlement has been reached which, if approved by the courts and fully implemented, will resolve Vioxx claims across Canada.Click here for more information
View the post titled Vioxx Settlement ReachedSiskinds is pleased to launch Siskinds New Year Charity Challenge – a unique opportunity for any London charity or non-profit to win $5,000.00 to give back to our local community.
Please see www.facebook.com/siskinds for more details
View the post titled Siskinds is pleased to launch Siskinds New Year Charity Challenge – a unique opportunity for any London charity or non-profit to win $5,000.00 to give back to our local community.Sino-Forest issues warning about financial statements.
Thestar.com reports on Siskinds class action against Sino-Forest.To read full article, please visit http://www.thestar.com/article/1114154–sino-forest-issues-warning-about-financial-statements.
View the post titled Sino-Forest issues warning about financial statements.Sino-Forest debt holders to oversee liquidation.
The Globe and Mail reports on Siskinds class action against Sino-Forest.To read the full story, please visit http://www.theglobeandmail.com/globe-investor/sino-forest-debt-holders-to-oversee-asset-sales/article1360317/.
View the post titled Sino-Forest debt holders to oversee liquidation.Canada-wide Neurontin® Class Action – Notice of Certification.
Canada Newswire reports on Siskinds class action class action relating to the drug Neurontin®.To read full story, please visit http://www.newswire.ca/en/story/903975/canada-wide-neurontin-class-action-notice-of-certification.
View the post titled Canada-wide Neurontin® Class Action – Notice of Certification.Koskie, Siskinds to Lead Class-Action Suit Against Sino-Forest
Businessweek reports on Siskinds winning approval from an Ontario judge to lead an investor class-action lawsuit against Sino-Forest Corp. For more information, please click here.
View the post titled Koskie, Siskinds to Lead Class-Action Suit Against Sino-ForestSiskinds is proud to announce that Scott Ritchie and Charles Wright have been named to the 2012 Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada.
Selection to the 2012 Lexpert / ALM 500 Directory is limited only to the top 500 vote recipients in the survey who are the considered the Most Frequently Recommended by their peers. It is a special honour and Siskinds congratulates Scott and Charles. For more information, please visit http:…
View the post titled Siskinds is proud to announce that Scott Ritchie and Charles Wright have been named to the 2012 Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada.Snap London shares a photo of James Caskey and Beth Traynor, partners at Siskinds.
Jim Caskey along with Orchestra London and Unity Project for Relief of Homelessness participated in the Dickens’ A Christmas Carol fundraiser. To view, please visit http://www.snaplondon.ca/?option=com_sngevents&id[]=346602&utm_source=email&utm_medium=snapd
View the post titled Snap London shares a photo of James Caskey and Beth Traynor, partners at Siskinds.Receive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.